99 related articles for article (PubMed ID: 1391665)
1. Variable region differences affect antibody binding to immobilized but not soluble antigen.
Horgan C; Brown K; Pincus SH
Hum Antibodies Hybridomas; 1992 Jul; 3(3):153-7. PubMed ID: 1391665
[TBL] [Abstract][Full Text] [Related]
2. Effect of H chain V region on complement activation by immobilized immune complexes.
Horgan C; Brown K; Pincus SH
J Immunol; 1992 Jul; 149(1):127-35. PubMed ID: 1607649
[TBL] [Abstract][Full Text] [Related]
3. Studies on antigen binding by intact and hinge-deleted chimeric antibodies.
Horgan C; Brown K; Pincus SH
J Immunol; 1993 Jun; 150(12):5400-7. PubMed ID: 7685795
[TBL] [Abstract][Full Text] [Related]
4. Alteration in H chain V region affects complement activation by chimeric antibodies.
Horgan C; Brown K; Pincus SH
J Immunol; 1990 Oct; 145(8):2527-32. PubMed ID: 2120333
[TBL] [Abstract][Full Text] [Related]
5. A peptide sequence mimics the epitope on the multideterminant antigen (Tyr,Glu)-Ala-Lys that induces the dominant H10/V kappa 1+ primary antibody response.
Giorgetti CA; Press JL
J Immunol; 1994 Jan; 152(1):136-45. PubMed ID: 7504708
[TBL] [Abstract][Full Text] [Related]
6. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
8. Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning.
Klimka A; Matthey B; Roovers RC; Barth S; Arends JW; Engert A; Hoogenboom HR
Br J Cancer; 2000 Jul; 83(2):252-60. PubMed ID: 10901379
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.
Fellouse FA; Barthelemy PA; Kelley RF; Sidhu SS
J Mol Biol; 2006 Mar; 357(1):100-14. PubMed ID: 16413576
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
[TBL] [Abstract][Full Text] [Related]
11. Molecular and kinetic analysis of an epitope-specific shift in the B cell memory response to a multideterminant antigen.
Press JL; Giorgetti CA
J Immunol; 1993 Aug; 151(4):1998-2013. PubMed ID: 7688392
[TBL] [Abstract][Full Text] [Related]
12. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
16. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
17. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
18. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
19. Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?
Pritsch O; Hudry-Clergeon G; Buckle M; Petillot Y; Bouvet JP; Gagnon J; Dighiero G
J Clin Invest; 1996 Nov; 98(10):2235-43. PubMed ID: 8941639
[TBL] [Abstract][Full Text] [Related]
20. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
